Scientists have developed a new therapy to combat deadly bacteria that is infecting hospital patients worldwide.
The new therapy—a biocide that is able to target antibiotic-defiant bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA)—was developed by scientists at the University of Waterloo and University of Manitoba.
“We wanted to be able to help vulnerable patients suffering from chronic infections,” said Emmanuel Ho, a professor in the School of Pharmacy at the University of Waterloo. “Once they’re infected with a resistant strain of bacteria it’s very difficult to get them well again.”
This latest development provides hope in an age where bacteria are becoming resistant to antibiotics faster than researchers can develop new ones. The World Health Organization estimates 700,000 people die annually from antibiotic-resistant infections and they expect this toll to climb to 10 million by 2050, higher than the current death rate from cancer.
University of Manitoba researcher Song Liu created a potent biocide that kills all bacterial cells - even the antibiotic-resistant ones - that it comes in contact with. The biocide was limited to surface wounds due to its poor selectivity between bacterial and mammalian cells, but if they could deliver the biocide to a target inside the body, it would kill even the most resistant superbug.
Read more at: University of Waterloo
Image Credit: University of Waterloo